Comparison between direct factor Xa inhibitors and low-molecular-weight heparin for efficacy and safety in the treatment of cancer-associated venous thromboembolism: A meta-analysis
J Cancer Res Ther
; 2020 Jan; 15(6): 1541-1546
Article
| IMSEAR
| ID: sea-213568
Full text:
1
Index:
IMSEAR
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Systematic_reviews
Journal:
J Cancer Res Ther
Journal subject:
Neoplasms
/
Therapeutics
Year:
2020
Type:
Article